Innovations in the Spotlight

Innovations in the Spotlight

Innovations in the Spotlight

Innovation

Jun 24, 2026

TargED Raises €40.4M Series A2 to Advance First-in-Class Targeted Thrombolytic TGD001

TargED Biopharmaceuticals B.V., a clinical-stage biotechnology company developing next-generation targeted treatments for thrombotic diseases, today announced the second and final closing of its Series A2 round totaling €40.4 million. The second closing brought in new investors Kurma Partners (Eurazeo Group) and the European Innovation Council (EIC) Fund, alongside additional participation from existing investors Inkef and Curie Capital.

Innovation

Jun 24, 2026

TargED Raises €40.4M Series A2 to Advance First-in-Class Targeted Thrombolytic TGD001

TargED Biopharmaceuticals B.V., a clinical-stage biotechnology company developing next-generation targeted treatments for thrombotic diseases, today announced the second and final closing of its Series A2 round totaling €40.4 million. The second closing brought in new investors Kurma Partners (Eurazeo Group) and the European Innovation Council (EIC) Fund, alongside additional participation from existing investors Inkef and Curie Capital.

Innovation

Jun 24, 2026

TargED Raises €40.4M Series A2 to Advance First-in-Class Targeted Thrombolytic TGD001

TargED Biopharmaceuticals B.V., a clinical-stage biotechnology company developing next-generation targeted treatments for thrombotic diseases, today announced the second and final closing of its Series A2 round totaling €40.4 million. The second closing brought in new investors Kurma Partners (Eurazeo Group) and the European Innovation Council (EIC) Fund, alongside additional participation from existing investors Inkef and Curie Capital.

Innovation

Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis

Innovation

Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis

Innovation

Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis

Innovation

Making label-free biosensing more accessible to every lab

Innovation

Making label-free biosensing more accessible to every lab

Innovation

Making label-free biosensing more accessible to every lab

Innovation

HAN BioCentre partner in Groeifonds Cellulaire Agricultuur en FungCows

Innovation

HAN BioCentre partner in Groeifonds Cellulaire Agricultuur en FungCows

Innovation

HAN BioCentre partner in Groeifonds Cellulaire Agricultuur en FungCows

Innovation

Confo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate

Innovation

Confo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate

Innovation

Confo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate

Innovation

Khondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease

Innovation

Khondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease

Innovation

Khondrion Announces First Patient Dosed in Pivotal Phase 3 KHENERFIN Study of Sonlicromanol in Mitochondrial DNA 3243A>G Primary Mitochondrial Disease

Innovation

Utrecht scientists reveal that metastasis-related changes occur early in colon cancer

Innovation

Utrecht scientists reveal that metastasis-related changes occur early in colon cancer

Innovation

Utrecht scientists reveal that metastasis-related changes occur early in colon cancer

Innovation

An important step forward in the fight against antimicrobial resistance (AMR)

Innovation

An important step forward in the fight against antimicrobial resistance (AMR)

Innovation

An important step forward in the fight against antimicrobial resistance (AMR)

Innovation

Syntric Medical Wins Venture Challenge Medtech Winter 2026 Edition

Innovation

Syntric Medical Wins Venture Challenge Medtech Winter 2026 Edition

Innovation

Syntric Medical Wins Venture Challenge Medtech Winter 2026 Edition

Innovation

From overlooked to in demand: Femtech in focus at Women’s Health Pitch Session at I4H2026

Innovation

From overlooked to in demand: Femtech in focus at Women’s Health Pitch Session at I4H2026

Innovation

From overlooked to in demand: Femtech in focus at Women’s Health Pitch Session at I4H2026

Load More Innovation News

Featured

MORE

Career

Scientists with outstanding achievements in their field often struggle to raise funds effectively

Career

Scientists with outstanding achievements in their field often struggle to raise funds effectively

Industry

Globally Recognized Impact Investors Back Leyden Labs’ Mission to Transform Protection Against Respiratory Viruses with €40 Million Investment

Industry

Globally Recognized Impact Investors Back Leyden Labs’ Mission to Transform Protection Against Respiratory Viruses with €40 Million Investment

Startup

Omivera wil geneesmiddelen ontwikkeling versnellen met betere data | Start-up Spotlight Universiteit Leiden, Deel 1 van 3

Startup

Omivera wil geneesmiddelen ontwikkeling versnellen met betere data | Start-up Spotlight Universiteit Leiden, Deel 1 van 3

Startup

How MyClusters is Using Real-World Data to Improve Care for Cluster Headache Patients

Startup

How MyClusters is Using Real-World Data to Improve Care for Cluster Headache Patients

Career

Scientists with outstanding achievements in their field often struggle to raise funds effectively

Industry

Globally Recognized Impact Investors Back Leyden Labs’ Mission to Transform Protection Against Respiratory Viruses with €40 Million Investment

Startup

Omivera wil geneesmiddelen ontwikkeling versnellen met betere data | Start-up Spotlight Universiteit Leiden, Deel 1 van 3

Advertisement

Advertisement